Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Given Average Rating of "Buy" by Brokerages
Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating) have received an average rating of “Buy” from the eleven brokerages that are currently covering the firm, MarketBeat.com reports. Eight investment analysts have rated the stock with a buy rating. The average 1-year target price among brokers that have issued ratings on the stock in the […]